ABBOTT LABORATORIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.3 USD | -0.84% |
|
-2.43% | -7.03% |
| Jul. 02 | Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating | MT |
| Jul. 01 | Abbott Laboratories(NYSE:ABT) dropped from Russell 3000E Growth Index | CI |
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:
- diagnostic systems and instruments (39.1%);
- vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.;
- nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products;
- medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;
- other (15.9%).
Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Calendar
2024-07-14
- Détachement de
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.3
USD
Average target price
124.9
USD
Spread / Average Target
+22.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.03% | 178B | |
| -6.32% | 98.95B | |
| -6.15% | 66.14B | |
| -10.62% | 44.11B | |
| +8.34% | 43.82B | |
| +11.91% | 42.07B | |
| +11.64% | 28.92B | |
| +17.68% | 24.69B | |
| -8.87% | 23.38B | |
| -12.42% | 21.93B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Insider Sell: Abbott Laboratories
